Acute renal failure as the first presenting sign of non-Hodgkin's lymphoma. 2004

B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
Department of Nuclear Medicine, Mont-Godinne Medical Center, Université Catholique de Louvain, Dr G. Therasse 1, 5530 Yvoir, Belgium. bruno.krug@mnuc.ucl.ac.be

UI MeSH Term Description Entries
D008297 Male Males
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F

Related Publications

B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
January 1996, Nephron,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
September 1994, Scandinavian journal of urology and nephrology,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
December 2015, Journal of clinical and experimental hepatology,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
February 1988, The American journal of medicine,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
August 1999, Nihon Jinzo Gakkai shi,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
January 1992, Nephron,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
June 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
January 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
January 1997, Acta haematologica,
B Krug, and B Willemart, and I Mathieu, and A S Pirson, and D Luyx, and A Sonet, and A Bosly, and T Vander Borght
January 2006, Journal of nephrology,
Copied contents to your clipboard!